GC Rieber VivoMega, a supplier of omega-3 concentrates, has announced a $75m investment plan to build a facility at its Norwegian manufacturing campus. Planned to be operational in early 2024, the facility will enable GC Rieber to more than double its output of EPA and DHA. 

To support future raw material sources, the Norwegian facility is also being designed with added flexibility to support future growth areas in omega-3 concentrates.

“This investment is part of GC Rieber VivoMega’s continual commitment to develop the needed facilities for the increased capacity and production of our industry leading omega-3 oils,” said Jan Roger Bjerkestrand, MD of GC Rieber VivoMega. “To minimise our eco-footprint, we will be leveraging much of the existing infrastructure, including docks, tanks, laboratories, and energy to provide the same high-quality product that our customers are asking for.” 

During the summer of 2022, the company aims to complete construction of a 32,000 metric ton tank park and updat the technology platform used at its existing manufacturing plants. 

“We are encouraged that this new development will enable GC Rieber VivoMega to continue to grow and expand as a leading high-end omega-3 supplier,” said Bjerkestrand. “With one of the world’s largest fish oil manufacturing and storage facilities, the expansion will provide GC Rieber VivoMega with added flexibility to meet our customers’ ongoing supply needs.”